ReviewPharmacology research & perspectives2021

Exploring the Food and Drug Administration's review and approval of Entresto (sacubitril/valsartan).

Ashley L Eadie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.